News
CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...
The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate ...
A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB-102 trial.
DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin, suggesting ...
CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.
Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, an oncology nurse practitioner at HonorHealth Research Institute (HRI), is a ...
JAK inhibitors ease symptoms in myelofibrosis, but only stem cell transplant offers a cure; newer drugs aim to fill unmet ...
I'm a follicular lymphoma survivor, and hearing others name the quiet, lasting changes of life after cancer made me feel seen ...
The FDA'S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma ...
ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...
I’ve lived with large granular lymphocytic leukemia for 16 years and have learned to spend my energy wisely, embrace ...
I found purpose after my AML diagnosis by reflecting on loss, embracing gratitude and using my experience to help others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results